# -*- coding: utf-8 -*-
"""
本地化肺癌药物靶点分析脚本
避免外部网络依赖，基于本地知识和数据
"""
import sys
import io

# 设置 UTF-8 输出
sys.stdout = io.TextIOWrapper(sys.stdout.buffer, encoding='utf-8')
sys.stderr = io.TextIOWrapper(sys.stderr.buffer, encoding='utf-8')

def analyze_lung_cancer_targets():
    """本地化肺癌药物靶点分析"""

    print("🧬 肺癌药物靶点筛选分析")
    print("=" * 60)

    # 肺癌关键药物靶点（基于现有医学知识）
    key_targets = {
        "EGFR": {
            "全称": "表皮生长因子受体",
            "重要性": "肺癌治疗中最成熟的靶点之一",
            "状态": "已有多款上市药物",
            "药物示例": ["吉非替尼", "厄洛替尼", "奥希替尼"]
        },
        "ALK": {
            "全称": "间变性淋巴瘤激酶",
            "重要性": "NSCLC中的重要驱动基因",
            "状态": "靶向治疗效果显著",
            "药物示例": ["克唑替尼", "阿来替尼", "布加替尼"]
        },
        "ROS1": {
            "全称": "ROS原癌基因1",
            "重要性": "NSCLC中的罕见靶点",
            "状态": "靶向治疗敏感",
            "药物示例": ["克唑替尼", "恩曲替尼"]
        },
        "KRAS": {
            "全称": "KRAS原癌基因",
            "重要性": "最常见的肺癌驱动突变",
            "状态": "传统难靶向，近期有突破",
            "药物示例": ["索托拉西布", "阿达格拉西布"]
        },
        "MET": {
            "全称": "MET原癌基因",
            "重要性": "MET exon14跳跃突变",
            "状态": "新兴治疗靶点",
            "药物示例": ["卡马替尼", "特泊替尼"]
        },
        "PD-1/PD-L1": {
            "全称": "程序性死亡受体1/配体",
            "重要性": "免疫检查点抑制剂靶点",
            "状态": "免疫治疗的核心靶点",
            "药物示例": ["帕博利珠单抗", "纳武利尤单抗", "阿替利珠单抗"]
        }
    }

    # ADMET 性质评估要点
    admet_factors = {
        "吸收": {
            "口服生物利用度": "理想值>50%",
            "溶解度": "影响吸收的关键因素",
            "渗透性": "Caco-2模型评估"
        },
        "分布": {
            "蛋白结合率": "影响药物浓度",
            "组织分布": "肺部组织富集",
            "血脑屏障": "需要根据治疗目的评估"
        },
        "代谢": {
            "肝酶代谢": "CYP450酶系",
            "代谢稳定性": "t1/2 > 6小时为理想",
            "药物相互作用": "避免酶抑制或诱导"
        },
        "排泄": {
            "肾脏排泄": "肾功能不全患者调整剂量",
            "胆汁排泄": "肝功能影响清除"
        },
        "毒性": {
            "心脏毒性": "QT间期延长风险",
            "肝脏毒性": "ALT/AST监测",
            "骨髓抑制": "血细胞计数监测"
        }
    }

    # 脱靶风险评估
    off_target_risks = {
        "激酶交叉反应": "激酶抑制剂常见问题",
        "hERG通道抑制": "心脏毒性风险",
        "CYP450抑制": "药物相互作用",
        "核受体结合": "代谢酶诱导/抑制"
    }

    print("\n📊 肺癌关键药物靶点分析")
    print("-" * 60)

    for target, info in key_targets.items():
        print(f"\n🎯 {target} - {info['全称']}")
        print(f"   重要性: {info['重要性']}")
        print(f"   状态: {info['状态']}")
        print(f"   现有药物: {', '.join(info['药物示例'])}")

    print("\n" + "=" * 60)
    print("🔬 ADMET 性质评估要点")
    print("-" * 60)

    for category, factors in admet_factors.items():
        print(f"\n📋 {category}:")
        for factor, description in factors.items():
            print(f"   • {factor}: {description}")

    print("\n" + "=" * 60)
    print("⚠️  脱靶风险评估关键点")
    print("-" * 60)

    for risk, description in off_target_risks.items():
        print(f"   • {risk}: {description}")

    print("\n" + "=" * 60)
    print("💡 药物筛选建议")
    print("-" * 60)

    recommendations = [
        "优先选择已验证的靶点（如EGFR、ALK）",
        "关注KRAS G12C等新兴靶点的机会",
        "考虑联合免疫治疗策略",
        "ADMET优化重点：口服生物利用度、代谢稳定性",
        "脱靶风险：重点评估激酶交叉反应",
        "考虑患者的个体化差异（基因突变状态）"
    ]

    for i, rec in enumerate(recommendations, 1):
        print(f"   {i}. {rec}")

    print("\n" + "=" * 60)
    print("🚨 分析完成")
    print("=" * 60)

    print("\n📝 后续步骤建议:")
    print("1. 选择2-3个优先靶点进行深入研究")
    print("2. 使用计算化学工具进行虚拟筛选")
    print("3. 选择top候选化合物进行实验验证")
    print("4. 系统评估ADMET性质和脱靶风险")
    print("5. 基于结构优化改进候选化合物")

def main():
    """主函数"""
    analyze_lung_cancer_targets()

if __name__ == "__main__":
    main()
